VEGF overexpression improves mesenchymal stem cell sheet transplantation therapy for acute myocardial infarction

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 9, 2013, Pages 742-750

  Augustin, Mona ^a,b   Mahar, Muhammad Ali Asim ^a,b   Lakkisto, Päivi ^a,c   Tikkanen, Ilkka ^a,c   Vento, Antti ^a   Pätilä, Tommi ^a   Harjula, Ari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Mesenchymal stem cells; Sheet therapy; VEGF

Indexed keywords

CARDIOLOGY; CELL DEATH; CELL ENGINEERING; DISEASE CONTROL; DISEASES; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; FLOWCHARTING; RATS; STEM CELLS; TISSUE ENGINEERING;

ACUTE MYOCARDIAL INFARCTION; CELL SHEET; FUNCTIONAL RECOVERY; HYPOXIC CONDITION; IN-VITRO; MESENCHYMAL STEM CELL; OVEREXPRESSIONS; SHEET THERAPY; TRANSPLANTATION THERAPY; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CELL CULTURE;

CASPASE 3; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSPLANTATION;

EID: 84882289365     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1471     Document Type: Article

References (33)

1. Anversa P, Nadal-Ginard B. 2002; Myocyte renewal and ventricular remodeling. Nature 415: 240-243.
2. Bizik J, Kankuri E, Ristimaki A, et al. 2004; Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 11: 183-195.
3. Caplan AI, Dennis JE. 2006; Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5): 1076-1084.
4. Davani S, Marandin A, Mersin N, et al. 2003; Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108: 253-258.
5. Gnecchi M, Zhang Z, Ni A, et al. 2008; Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103(11): 1204-1219.
6. Greijer AE, van der Wall E. 2004; The role of hypoxia inducible factor 1 (HIF-1) in hypoxia-induced apoptosis. J Clin Pathol 2004; 57: 1009-1014.
7. Hata H, Matsumiya G, Miyagawa S, et al. 2006; Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg 132(4): 918-924.
8. Haider HK, Ashraf MJ. 2010; Preconditioning and stem cell survival. Cardiovasc Transl Res 3(2): 89-102.
9. Hamdi H, Planat-Benard V, Bel A, et al. 2011; Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 91(3): 483-491.
10. Hatzistergos KE, Blum A, Ince T, et al. 2011; What is the oncologic risk of stem cell treatment for heart disease? Circ Res 108(11): 1300-1303.
11. Hirose M, Kwon OH, Yamato M, et al. 2000; Creation of designed shape cell sheets that are noninvasively harvested and moved onto another surface. Biomacromolecules 1: 377-381.
12. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. 2002; Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
13. Krampera M, Glennie S, Dyson J, et al. 2003; Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722.
14. Krijnen PA, Nijmeijer R, Meijer CJ, et al. 2002; Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 55: 801-811.
15. Kushida A, Yamato M, Konno C, et al. 1999; Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfaces. J Biomed Mater Res 45: 355-362.
16. Le Blanc K, Rasmusson I, Sundberg B, et al. 2004; Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439.
17. Nayan M, Paul A, Chen G, et al. 2011; Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: in vitro and in vivo investigation. J Tissue Eng 2011:741213. Epub 2011 July 24.
18. Masuda S, Shimizu T, Yamamoto M, et al. 2008; Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60(2): 277-285.
19. Memon IA, Sawa Y, Fukushima N, et al. 2005; Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 130(5): 1333-1341.
20. Miyahara Y, Nagaya N, Kataoka M, et al. 2006; Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12(4): 459-465.
21. Nagaya N, Kangawa K, Itoh T, et al. 2005; Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112; 1128-1135.
22. Okano T, Yamada H, Sakai H, et al. 1993; A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J Biomed Mater Res 27: 1243-1251.
23. Palojoki E, Saraste A, Eriksson A, et al. 2001; Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280: H2726.
24. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
25. Reyes M, Dudek A, Jahagirdar B, et al. 2002; Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346.
26. Sekine H, Shimizu T, Dobashi I, et al. 2011; Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 17(23-24): 2973-2980.
27. Miyagawa S, Roth M, Saito A, et al. 2011; Tissue-engineered cardiac constructs for cardiac repair. Ann Thorac Surg 91: 320-329.
28. Shimizu T, Yamato M, Isoi Y, et al. 2002; Fabrication of pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90: 40-48.
29. Shabbir A, Zisa D, Suzuki G, et al. 2009; Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296(6): H1888-1897.
30. Stein I, Itin A, Einat P, et al. 1998; Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18(6): 3112-3119.
31. Toma C, Pittenger MF, Cahill KS, et al. 2002; Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
32. Uccelli A, Moretta L, Pistoia V. 2006; Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36(10): 2566-2573.
33. Wang JS, Shum-Tim D, Galipeau J, et al. 2000; Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120: 999-1005.